Literature DB >> 26370254

Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.

Xihe Zhao1,2, Ping Wang1,2, Jing Liu3, Jian Zheng3, Yunhui Liu3, Jiajia Chen1,2, Yixue Xue1,2.   

Abstract

Aberrant expression of noncoding RNAs in glioma cells, including long noncoding RNAs (lncRNAs) and microRNAs, may participate in the progression of glioma. Encoded by Growth Arrest-Specific 5 (GAS5) gene, lncRNA Gas5 was reported to be a negative regulator for survival and proliferation of several cancers. Here, Gas5 is found to be downregulated in glioma specimens and U87 and U251 glioma cell lines. We showed that the introduction of Gas5 by plasmid transfection increased the expression of tumor suppressor Bcl-2-modifying factor (bmf) and Plexin C1 via directly targeting and reducing the expression of miR-222. Downregulated expression of miR-222 inhibited U87 and U251 cell proliferation and promoted the apoptosis by upregulating bmf. As downstream signaling molecules of bmf, Bcl-2 and Bax were involved in the process. Meanwhile, knockdown of miR-222 attenuated U87 and U251 cell migration and invasion by upregulating Plexin C1, and cofilin was a crucial regulator targeted by Plexin C1. Gas5 combined with the knockdown of miR-222 resulted in the smallest tumor volumes and the longest survivals of nude mice in vivo. In summary, we show that Gas5 suppresses tumor malignancy by downregulating miR-222, which may serve as a promising therapy for glioma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26370254      PMCID: PMC4700110          DOI: 10.1038/mt.2015.170

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  46 in total

1.  Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1.

Authors:  Kanami Uesugi; Izumi Oinuma; Hironori Katoh; Manabu Negishi
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

2.  MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.

Authors:  X Rao; G Di Leva; M Li; F Fang; C Devlin; C Hartman-Frey; M E Burow; M Ivan; C M Croce; K P Nephew
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

3.  Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.

Authors:  Michela Visani; Dario de Biase; Gianluca Marucci; Serenella Cerasoli; Evandro Nigrisoli; Maria Letizia Bacchi Reggiani; Fiorenzo Albani; Agostino Baruzzi; Annalisa Pession
Journal:  Mol Oncol       Date:  2013-12-24       Impact factor: 6.603

4.  Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.

Authors:  M E Fiori; C Barbini; T L Haas; N Marroncelli; M Patrizii; M Biffoni; R De Maria
Journal:  Cell Death Differ       Date:  2014-01-31       Impact factor: 15.828

5.  A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.

Authors:  R K Nam; W W Zhang; D A Loblaw; L H Klotz; J Trachtenberg; M A S Jewett; A Stanimirovic; T O Davies; A Toi; V Venkateswaran; L Sugar; K A Siminovitch; S A Narod
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-09-18       Impact factor: 5.554

Review 6.  Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Authors:  Dieta Brandsma; Lukas Stalpers; Walter Taal; Peter Sminia; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

7.  Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5).

Authors:  Mirna Mourtada-Maarabouni; Vanessa L Hedge; Lucy Kirkham; Farzin Farzaneh; Gwyn T Williams
Journal:  J Cell Sci       Date:  2008-04-01       Impact factor: 5.285

8.  Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway.

Authors:  Junichi Hitomi; Dana E Christofferson; Aylwin Ng; Jianhua Yao; Alexei Degterev; Ramnik J Xavier; Junying Yuan
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

9.  MicroRNAs 221 and 222 bypass quiescence and compromise cell survival.

Authors:  Ricardo Medina; Sayyed K Zaidi; Chang-Gong Liu; Janet L Stein; Andre J van Wijnen; Carlo M Croce; Gary S Stein
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

10.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

View more
  81 in total

1.  Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.

Authors:  Chen Jin; Jie Zhao; Zhi-Ping Zhang; Ming Wu; Jian Li; Ge-Lei Xiao; Bo Liu; Yu-Xiang Liao; Jing-Ping Liu
Journal:  J Neurooncol       Date:  2020-05-29       Impact factor: 4.130

2.  GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma.

Authors:  Xiao Dong; Chuize Kong; Xiankui Liu; Jianbin Bi; Zhenhua Li; Zeliang Li; Yuyan Zhu; Zhe Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

3.  LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.

Authors:  Guoxiong Li; Yingqian Cai; Chuanmei Wang; Min Huang; Jiansheng Chen
Journal:  J Neurooncol       Date:  2019-06-06       Impact factor: 4.130

4.  LLCLPLDA: a novel model for predicting lncRNA-disease associations.

Authors:  Guobo Xie; Shuhuang Huang; Yu Luo; Lei Ma; Zhiyi Lin; Yuping Sun
Journal:  Mol Genet Genomics       Date:  2019-06-28       Impact factor: 3.291

5.  LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.

Authors:  Dong Xue; Cuixing Zhou; Hao Lu; Renfang Xu; Xianlin Xu; Xiaozhou He
Journal:  Tumour Biol       Date:  2016-10-14

6.  lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.

Authors:  Peng Gu; Xu Chen; Ruihui Xie; Jinli Han; Weibin Xie; Bo Wang; Wen Dong; Changhao Chen; Meihua Yang; Junyi Jiang; Ziyue Chen; Jian Huang; Tianxin Lin
Journal:  Mol Ther       Date:  2017-05-06       Impact factor: 11.454

7.  Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells.

Authors:  Juntao Li; Lin Li; Huozhong Yuan; Xing-Wei Huang; Tianxin Xiang; Sujuan Dai
Journal:  Cell Cycle       Date:  2019-07-07       Impact factor: 4.534

8.  The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.

Authors:  Yanhua Li; Junjiao Gu; Hong Lu
Journal:  Dig Dis Sci       Date:  2017-11-02       Impact factor: 3.199

9.  Effects of small nucleolar RNA SNORD44 on the proliferation, apoptosis and invasion of glioma cells.

Authors:  Xian-Ru Xia; Wen-Cui Li; Zong-Tao Yu; Jie Li; Chun-Yan Peng; Li Jin; Guo-Lin Yuan
Journal:  Histochem Cell Biol       Date:  2020-02-15       Impact factor: 4.304

Review 10.  A critical overview of long non-coding RNA in glioma etiology 2016: an update.

Authors:  Yuan-Feng Gao; Zhi-Bin Wang; Tao Zhu; Chen-Xue Mao; Xiao-Yuan Mao; Ling Li; Ji-Ye Yin; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.